ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

19 links0 made here, not in the record35 judgments2 judges (the rules as one: Rule based)16 record changes seen
Claude Opus 5.5Rule basedRecord updated on ClinicalTrials.govReplaced, or read an older version
Sep 28Oct 5Oct 12Oct 19Oct 26Nov 2Nov 9Nov 16TodayNCT05564377Targeted Therapy Directedby Genetic Testing inTreating Patients WithLocally Advanced orAdvanced Solid Tumors, TheComboMATCH Screening TrialNational Cancer Institute (NCIPhase 2 · recruitingRECORDThe record itselfVersions seen nightly since Sep 25, 2…›Sep 28 · ClinicalTrials.gov record · Version of 2026-09-28Sep 29 · ClinicalTrials.gov record · Version of 2026-09-29Oct 1 · ClinicalTrials.gov record · Version of 2026-10-01Oct 2 · ClinicalTrials.gov record · Version of 2026-10-02Oct 5 · ClinicalTrials.gov record · Version of 2026-10-05Oct 6 · ClinicalTrials.gov record · Version of 2026-10-06Oct 7 · ClinicalTrials.gov record · Version of 2026-10-07Oct 8 · ClinicalTrials.gov record · Version of 2026-10-08Oct 14 · ClinicalTrials.gov record · Version of 2026-10-14Oct 15 · ClinicalTrials.gov record · Version of 2026-10-15Oct 26 · ClinicalTrials.gov record · Version of 2026-10-26Oct 28 · ClinicalTrials.gov record · Version of 2026-10-28Oct 30 · ClinicalTrials.gov record · Version of 2026-10-30Nov 2 · ClinicalTrials.gov record · Version of 2026-11-02Nov 12 · ClinicalTrials.gov record · Version of 2026-11-12Nov 18 · ClinicalTrials.gov record · Version of 2026-11-18Version of 2026-11-18CONDITIONSNeoplasm MetastasisThe registry's MeSH filing›As of now · Rule based · Main conditionMain conditionEndometrial NeoplasmsThe registry's MeSH filing›No judgment recorded. Shown as the registry files it.Fallopian Tube NeoplasmsThe registry's MeSH filing›No judgment recorded. Shown as the registry files it.Ovarian NeoplasmsThe registry's MeSH filing›No judgment recorded. Shown as the registry files it.DRUGSAlpelisibIntervention entry›Nov 3 · Claude Opus 5.5 · TestedNov 10 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedBinimetinibIntervention entry›Nov 3 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedFluorouracilIntervention entry›Nov 3 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedFulvestrantIntervention entry›Nov 3 · Claude Opus 5.5 · TestedNov 3 · Claude Opus 5.5 · Background · optionNov 18 · Rule based · TestedBackground · optionIpatasertibIntervention entry›Nov 3 · Claude Opus 5.5 · TestedNov 10 · Claude Opus 5.5 · Background · optionNov 18 · Rule based · TestedBackground · optionLeucovorinIntervention entry›Nov 3 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedNeratinibEntry “Neratinib Maleate”, read by ou…›Nov 3 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedNilotinibEntry “Nilotinib Hydrochloride Monohy…›Nov 3 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedOlaparibIntervention entry›Nov 3 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedOxaliplatinIntervention entry›Nov 3 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedPaclitaxelIntervention entry›Nov 3 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedPalbociclibIntervention entry›Nov 3 · Claude Opus 5.5 · TestedNov 3 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedPanitumumabIntervention entry›Nov 3 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedSelumetinib sulfateIntervention entry›Nov 3 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedSotorasibIntervention entry›Nov 3 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTested

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

Alpelisib

From the registry record3 judgments on this link
Role in the study, from the registry to what was judged
RegistryEntry “Alpelisib”the record gives no role
→judged=agrees=agrees
How the 3 judgments split100%of judgments with a known value say Tested
Tested · 3

All judgments on this study

WhenLinkJudgeDecisionState
Sep 28The record itselfClinicalTrials.gov recordVersion of 2026-09-28Record change
Sep 29The record itselfClinicalTrials.gov recordVersion of 2026-09-29Record change
Oct 1The record itselfClinicalTrials.gov recordVersion of 2026-10-01Record change
Oct 2The record itselfClinicalTrials.gov recordVersion of 2026-10-02Record change
Oct 5The record itselfClinicalTrials.gov recordVersion of 2026-10-05Record change
Oct 6The record itselfClinicalTrials.gov recordVersion of 2026-10-06Record change
Oct 7The record itselfClinicalTrials.gov recordVersion of 2026-10-07Record change
Oct 8The record itselfClinicalTrials.gov recordVersion of 2026-10-08Record change
Oct 14The record itselfClinicalTrials.gov recordVersion of 2026-10-14Record change
Oct 15The record itselfClinicalTrials.gov recordVersion of 2026-10-15Record change
Oct 26The record itselfClinicalTrials.gov recordVersion of 2026-10-26Record change
Oct 28The record itselfClinicalTrials.gov recordVersion of 2026-10-28Record change
Oct 30The record itselfClinicalTrials.gov recordVersion of 2026-10-30Record change
Nov 2The record itselfClinicalTrials.gov recordVersion of 2026-11-02Record change
Nov 3AlpelisibClaude Opus 5.5TestedReplaced
Nov 3BinimetinibClaude Opus 5.5TestedCurrent
Nov 3FluorouracilClaude Opus 5.5TestedCurrent
Nov 3FulvestrantClaude Opus 5.5TestedReplaced
Nov 3IpatasertibClaude Opus 5.5TestedReplaced
Nov 3LeucovorinClaude Opus 5.5TestedCurrent
Nov 3NeratinibClaude Opus 5.5TestedCurrent
Nov 3NilotinibClaude Opus 5.5TestedCurrent
Nov 3OlaparibClaude Opus 5.5TestedCurrent
Nov 3OxaliplatinClaude Opus 5.5TestedCurrent
Nov 3PaclitaxelClaude Opus 5.5TestedCurrent
Nov 3PalbociclibClaude Opus 5.5TestedReplaced
Nov 3PanitumumabClaude Opus 5.5TestedCurrent
Nov 3Selumetinib sulfateClaude Opus 5.5TestedCurrent
Nov 3SotorasibClaude Opus 5.5TestedCurrent
Nov 3FulvestrantClaude Opus 5.5Background · optionCurrent
Nov 3PalbociclibClaude Opus 5.5TestedCurrent
Nov 10AlpelisibClaude Opus 5.5TestedCurrent
Nov 10IpatasertibClaude Opus 5.5Background · optionCurrent
Nov 12The record itselfClinicalTrials.gov recordVersion of 2026-11-12Record change
Nov 18The record itselfClinicalTrials.gov recordVersion of 2026-11-18Record change
Nov 18AlpelisibRule based · role ruleTestedAgrees
Nov 18BinimetinibRule based · role ruleTestedAgrees
Nov 18FluorouracilRule based · role ruleTestedAgrees
Nov 18FulvestrantRule based · role ruleTestedOverridden
Nov 18IpatasertibRule based · role ruleTestedOverridden
Nov 18LeucovorinRule based · role ruleTestedAgrees
Nov 18NeratinibRule based · role ruleTestedAgrees
Nov 18NilotinibRule based · role ruleTestedAgrees
Nov 18OlaparibRule based · role ruleTestedAgrees
Nov 18OxaliplatinRule based · role ruleTestedAgrees
Nov 18PaclitaxelRule based · role ruleTestedAgrees
Nov 18PalbociclibRule based · role ruleTestedAgrees
Nov 18PanitumumabRule based · role ruleTestedAgrees
Nov 18Selumetinib sulfateRule based · role ruleTestedAgrees
Nov 18SotorasibRule based · role ruleTestedAgrees
As of nowNeoplasm MetastasisRule based · main-condition ruleMain conditionCurrent

The rules, in plain words

“Rule based” means one of these decided, not a model or a person. Each runs every night over every study.

Which drugs a study tests

Reads each treatment the study lists and the arms it is in. A drug only in the experimental arm is tested. A drug in every arm while something else changes between the arms is given beside it. A drug only in the control arm is the comparator. Placebo, procedures and usual care are known by name.

Where the whole record has been read, that reading's answer replaces the rule's.

What a study is mainly about

Starts from the first condition ClinicalTrials.gov files the study under. It moves to a narrower one only when the study's own title or listed conditions name it, and sets aside terms the registry often files by mistake. A study open to many cancers is not placed under one of them unless its title names it.

Checked against studies judged one by one; the study page says when it differs from the registry.